Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 17 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2017

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC

Crandall, J. P., Tahari, A. K., Juergens, R. A., Brahmer, J. R., Rudin, C. M., Esposito, G., Subramaniam, D. S., Knopp, M. V., Hall, N. C., Gajwani, P., Leal, J. P., Lodge, M. A., Joo, H. O., Gabrielson, E. W., Shankar, L. K. & Wahl, R. L. Dec 1 2017 In : EJNMMI Research. 7, 1, 8

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Positron-Emission Tomography
Tomography
Drug Therapy
Neoplasms

Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer

Anagnostou, V. , Smith, K. N. , Forde, P. M. , Niknafs, N. , Bhattacharya, R. , White, J. , Zhang, T. , Adleff, V. , Phallen, J. , Wali, N. , Hruban, C. , Guthrie, V. B. , Rodgers, K. , Naidoo, J. , Kang, H. , Sharfman, W. , Georgiades, C. , Verde, F. , Illei, P. , Li, Q. K. & 9 others Gabrielson, E., Brock, M. V., Zahnow, C. A., Baylin, S. B., Scharpf, R. B., Brahmer, J. R., Karchin, R., Pardoll, D. M. & Velculescu, V. E. Mar 1 2017 In : Cancer Discovery. 7, 3, p. 264-276 13 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Neoplasms
T-Lymphocytes
Mutation
T-Cell Antigen Receptor

Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer

Taunk, N. K., Rimner, A., Culligan, M., Friedberg, J. S., Brahmer, J. & Chaft, J. Apr 1 2017 In : Translational Lung Cancer Research. 6, 2, p. 178-185 8 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Immunotherapy
Radiation
Oncolytic Virotherapy
Dose Fractionation

Inflammatory arthritis: A newly recognized adverse event of immune checkpoint blockade

Naidoo, J., Cappelli, L. C., Forde, P. M., Marrone, K. A., Lipson, E. J., Hammers, H. J., Sharfman, W. H., Le, D. T., Baer, A. N., Shah, A. A., Albayda, J., Manno, R. L., Haque, U., Gutierrez, A. K., Bingham, C. O. & Brahmer, J. R. Jun 1 2017 In : Oncologist. 22, 6, p. 627-630 4 p.

Research output: Contribution to journalComment/debate

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study

Hellmann, M. D., Rizvi, N. A., Goldman, J. W., Gettinger, S. N., Borghaei, H., Brahmer, J. R., Ready, N. E., Gerber, D. E., Chow, L. Q., Juergens, R. A., Shepherd, F. A., Laurie, S. A., Geese, W. J., Agrawal, S., Young, T. C., Li, X. & Antonia, S. J. Jan 1 2017 In : The Lancet Oncology. 18, 1, p. 31-41 11 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Safety
Drug Therapy